Acta Anaesthesiologica Scandinavica · 1999 · 25 citations · 0 references
MedicinePediatricsPharmacotherapyHemostasisPediatric HematologyTransfusion MedicineCoagulation AbnormalitiesPediatric Tonsil DiseaseDrug-related HemorrhageFactor Viii ActivationFactor Viii AlterationsFactor Viii PhysiologySerious Adverse Drug ReactionsSerious Adverse Events
Desmopressin (DDAVP) may be used to augment the action of factor VIII in mild haemophilia. Its use has been associated with serious adverse effects. We report a case of a three-year-old child with a family history of haemophilia who suffered complications due to severe acute hyponatraemia following the administration of this drug for post-tonsillectomy bleeding.